Synonyms: compound 3 [PMID: 34675414]
Compound class:
Synthetic organic
Comment: SIM1 is a first-in-class trivalent PROTAC molecule [1]. It contains two bromo and extra terminal (BET) domain inhibitor ligand components and a von Hippel-Lindau (VHL) ligand domain which are tethered together by a branched linker. This approach increases the valency for target protein binding compared to earlier generation bivalent PROTAC molecules. SIM1 acts as a low picomolar BET degrader in vitro, and has favourable in vivo pharmacokinetics. BET inhibitors are being explored for anticancer activity.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
SIM1 binds to immobilised VHL with a Kd of 624 nM [1]. The binding affinity of SIM1/BRD2 complexes for VHL is higher at ~40 nM.In vitroSIM1 degrades BRD2 with a DC50 value of 1.1 nM, and reduces viability of MV4;11 AML cells with an IC50 of 1.1 nM. |
Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|